ALLO vs BEN · rev $22.0K vs P/E 36, rev $8.77B
Allogene Therapeutics Inc (ALLO) versus Franklin Resources Inc (BEN) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Franklin Resources Inc (BEN) is a asset management company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported BEN revenue for 2025-09-30 was $8.77B. Net income was $548.9M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
ALLO currently screens at market cap $258.1M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
Not investment advice. Open the ALLO and BEN stock pages for the full models.
Not investment advice.